Riad Bejta, PT

Semmelweis University 📚 PT Cardiopulmonary Rehabilitation

[ERS publications @ERSpublications]

ERJ Open Research: Gait speed <1.0 m/s in COPD independently predicts higher exacerbation risk, mortality and symptom burden over 3 years, despite similar lung function, highlighting its utility as a simple, integrative prognostic marker https://t.co/8v4BhfuaXo

[ERS Assembly 1 @ERSAssembly1]

🖥️Member’s Desk🖥️
💭 Can the 6-minute stepper (6MST) test accurately estimate endurance training intensity in people with COPD when cardiopulmonary exercise testing is unavailable?
🔗 https://t.co/Mt2GhSZn8D

[ERS publications @ERSpublications]

Incremental, symptom-limited CPET is safe in patients with suspected or confirmed pulmonary hypertension. In over 3800 tests, no deaths or syncopal events occurred, with an adverse event rate of only 0.05%, supporting wider use under proper supervision. https://t.co/1gQmXFNnCA

[ERS @EuroRespSoc]

📄 Now published: the new ERS Technical Standard on reference values for CPET – a summary report and call for action.

Access the new document and all associated content on the ERS Respiratory Channel: https://t.co/FjyzAK22P7

[Journal of Applied Physiology @japplphysiol]

Mini-Review by AA Hijleh et al. (@queensu) From #respiratorylimitation to dynamic depletion of #mechanical-#ventilatory reserves: a paradigm shift to probe #exertionaldyspnea with clinical #exercisetesting
https://t.co/bfkwbnvUik

[Lab3R @lab3_r]

📢 Are you involved in Pulmonary Rehabilitation?
🗓️ Don’t miss your opportunity to shape the future of interprofessional education in PR training in this @EuroRespSoc Task Force.
👉https://t.co/68vSuFQD3H

[ERS publications @ERSpublications]

The @EuroRespSoc guidelines for the management of bronchiectasis in adults provide an evidence-based framework for the management of patients with bronchiectasis https://t.co/4guuSNpbzh

[Felipe V. C. Machado @Machado_FVC]

Are you treating people with COPD and/or designing exercise intervention protocols for this population?

How do you adapt training when clinically relevant comorbidities are present?

🔗 https://t.co/IIe6ouNe9S

@SportsMedicineJ @pulmonary_rehab @fritsfranssen @hansen_phd

[ERS publications @ERSpublications]

Eur Respir J: Obstructive sleep apnoea increases cardiovascular and mortality risks. This study of 5358 patients followed over 14 years shows PAP therapy reduces long-term MACE and death risks by 16%. A calculator to estimate patient risk was created. https://t.co/6BmRT8YEzG

[CHEST® Journal @journal_CHEST]

A CHEST Review suggests that it should be a priority to identify early indicators of adverse reactions to chronic hypoxia and to validate their usefulness in deciding who should receive long-term oxygen therapy.

Read more: https://t.co/Q3rfbilzj9
#JournalCHEST #MedEd #COPD

[James D Chalmers @ProfJDChalmers]

Approved today: the first ever approved therapy for bronchiectasis in Europe
Congratulations investigators, patients and Insmed
Science changes lives
European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union - Nov 18, 2025
https://t.co/8qP8JEYEXd

[Nick Krontiris @nick_krontiris]

This study brings to light reliable biomarkers reflecting training load and V̇O2max that may enable personalized load monitoring of training and recovery after HIIT, of which particularly useful appears to be the logCK:logRBC ratio.

[Nick Krontiris @nick_krontiris]

The goal of this expert concensus statement was to propose standardized physical activity and exercise intensity terminology that has utility across all ages, sexes, genders, physical abilities, conditions, applications, and activities.

[ERS @EuroRespSoc]

🗞️ #ERSCongress 2025 in the headlines: exercise can help to restore a more normal, well-regulated immune system in people with post-COVID syndrome, according to a gold-standard RCT presented at the ERS Congress in Amsterdam, the Netherlands.

Learn more: https://t.co/NyMGss0xZW

[European Society of Cardiology @escardio]

Today is #WorldHeartDay! ❤️

At the European Society of Cardiology (ESC), our dedicated team stands together with one mission: to reduce the burden of cardiovascular disease worldwide.

Every heartbeat matters — and by raising awareness, advancing science, and supporting healthy hearts, we can make a difference. 💪🫀

Join us in spreading the message: take care of your heart and inspire others to do the same. Together, we can build a healthier future.

#DontMissABeat @worldheartfed

[ERS publications @ERSpublications]

ERJ Open Research: Short-duration, supramaximal HIIT is a feasible exercise modality in people with COPD. It enables high exercise intensities without excessive dyspnoea and supports the release of neurotrophic factors that can benefit cognitive function. https://t.co/FM2Ehn80NF

[Critical Care Science @critcarescience]

Do we underestimate right ventricle & venous system in #ICU?

➡️ RV function & VR: essential for🫀output & tissue perfusion
➡️ Guyton’s model & concept of mean systemic filling Press : insights into fluid & vasopressor mngment
🎯 Great narrative #Review

https://t.co/bnRBGzEPT6

[Saint-Clair Bernardes @fisiosaintclair]

New episode! Can we really predict respiratory failure?
We dive into a recent Critical Care paper and discuss how ICU PTs should apply clinical reasoning to anticipate deterioration and optimize treatment strategies.
🎙️Listen now on Spotify & YouTube! #utiemformaeacao

[Paul Wischmeyer MD @Paul_Wischmeyer]

🙋‍♂️New Must Read!

Muscle weakness after critical illness: unravelling biological mechanisms and clinical hurdles

New in @Crit_Care

https://t.co/mAsDeo9y2R #icurehab #A2Fbundle
#SCCM

[Christoph Burch @ChristophBurch]

Effects of Exercise Training on Mitochondrial and Capillary Growth in Human Skeletal Muscle: A Systematic Review and Meta-Regression
https://t.co/O1w9Ge7Kjr